arrow
P

Paschalis Karakasis

Aristotle University of Thessaloniki
H指数:24
被引数:5,809

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Complications After Permanent Pacemaker Implantation in Patients with Congenital Complete Atrioventricular Block: A Systematic Review and Meta-analysis

先天性完全性房室传导阻滞患者永久起搏器植入后的并发症:一项系统评价和Meta分析

2026-09-250
PRE
Three-Dimensional Left Atrial Geometry in Atrial Fibrillation: Imaging Biomarkers, Substrate Phenotyping, and Ablation Outcome Prediction

卡拉卡西斯等. 房颤中左心房的三维几何形态:成像生物标志物、基质分型和消融结果预测. 诊断学 2026, 16, 2255. [谷歌学术] [ CrossRef] [ Scilit] [PubMed]

2026-09-080
OA
Conduction system vs. biventricular pacing in heart failure with reduced ejection fraction: a meta-analysis of randomized controlled trials

射血分数降低的心力衰竭中传导系统起搏与双心室起搏的比较:一项随机对照试验的荟萃分析

2026-08-130
OAAI
Long-term efficacy and safety of left atrial appendage closure vs. oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials

心房颤动患者左心耳封堵术与口服抗凝药长期疗效和安全性比较:随机对照试验的Meta分析

2026-07-230
OAAI
Repurposing GLP-1 receptor agonists and SGLT-2 inhibitors in neurodegeneration and metabolically at-risk populations: Myth or reality? An overview of randomized clinical trials

GLP-1受体激动剂和SGLT-2抑制剂在神经退行性疾病及代谢高风险人群中的再利用:是神话还是现实?随机临床试验概述

2026-05-270
PRE
Comparative Efficacy and Safety of Catheter Ablation Energy Modalities for Atrial Fibrillation: A Network Meta-Analysis of Randomized Trials

心房颤动导管消融能量模式的比较疗效与安全性:随机试验的网络荟萃分析

2026-05-260
PRE
Changes in NT-proBNP Levels According to SGLT2 Inhibitor Use in Patients Hospitalized for Acute Heart Failure Decompensation: A Prospective Cohort Study

根据SGLT2抑制剂使用情况,急性心力衰竭失代偿住院患者NT-proBNP水平的改变:一项前瞻性队列研究

Life
IF3.4
2026-04-080
OAAI
Monitoring Atrial Fibrillation Using Wearable Digital Technologies: The Emerging Role of Smartwatches

使用可穿戴数字技术监测心房颤动:智能手表的兴起作用

2026-03-040
OAAI